- Assistant Professor, Global Health
325 Ninth Avenue
Seattle, WA 98104
Select from the following:
Patricia Pavlinac, PhD MS, is an epidemiologist and co-director of the Gut Health and Child Survival Scientific Priority Area. Dr. Pavlinac’s research aims to identify and test interventions to halt morbidity and mortality attributed to enteric and diarrheal diseases. Her other research interests include antibiotic resistance and pediatric tuberculosis.
- MS (University of Washington)
- BA (Colgate University)
- PhD (University of Washington)
- Child and Adolescent Health (incl. Pediatrics)
- Child Mortality
- Diarrheal Diseases
- Infectious Diseases (other than STDs)
- Maternal Child Health (incl. Reproductive Health)
- Antibiotics for Children with Severe Diarrhea (ABCD Trial)
- Azithromycin to prevent post-discharge morbidity and mortality in Kenyan children (Toto Bora Trial)
- Modulation of EPEC susceptibility and severity by an HIV- or antibiotic- altered intestinal microbiome.
- Optimal use of antibiotics in young children at high risk of diarrhea associated mortality.
Tickell KD, Brander RL, Atlas HE, Pernica JM, Walson JL, Pavlinac PB. Identification and management of Shigella infection in children with diarrhoea: a systematic review and meta-analysis. Lancet Global Health 2017; 5: e1235-e1248; PMC5695759
Pavlinac PB, Singa BO, John-Stewart GC, Richardson BA, Brander RL, McGrath CJ, Tickell KD, Amondi M, Rwigi D, Babigumira JB, Kariuki S, Nduati R, Walson JL. Azithromycin to prevent post-discharge morbidity and mortality in Kenyan children: a protocol for a randomised, double-blind, placebo-controlled trial (the Toto Bora trial). BMJ Open 2017; 7: e019170; PMC5778294
Brander RL, Walson JL, John-Stewart GC, Naulikha JM, Ndonye J, Kipkemoi N, Rwigi D, Singa BO, Pavlinac PB. Correlates of multi-drug non-susceptibility in enteric bacteria isolated from Kenyan children with acute diarrhea. PLoS Neglected Tropical Diseases 2017; 11: e0005974; PMC5638605
LaCourse SM, Cranmer LM, Njuguna IN, Gatimu J, Stern J, Maleche-Obimbo E, Walson JL, Wamalwa D, John-Stewart G, Pavlinac P, 2018. Urine TB lipoarabinomannan (LAM) predicts mortality in hospitalized HIV-infected children. Clin Infect Dis 2018;66(11): 1798-1801; PMC5961239